Charlotte G. J.
- Country
- Denmark
- Department
- Department of Urology
Research Overview
- Phase I/II Study of Intravesical Eciskafusp Alfa and Bacillus Calmette-Guérin in BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
- Evaluation of Reduced Dwell-Time Bacillus Calmette-Guérin (BCG) Instillation Regimen in High-Risk Non-Muscle Invasive Urothelial Carcinoma
- Randomized Controlled Trial of Nadofaragene Firadenovec Versus Observation in Intermediate Risk Non-Muscle Invasive Bladder Cancer
Data & Insights
Has run more than one trial at 24 of 58 partner sites.
Specializations
Urologic Oncology
The investigator specializes in treating non-muscle invasive bladder cancer, with particular emphasis on managing cases that have become unresponsive to conventional therapies.
- High-risk bladder cancer management
- BCG-unresponsive disease treatment
- Novel therapeutic approaches for bladder cancer
Their expertise extends to developing treatment strategies for patients with challenging bladder cancer presentations.
Immunotherapy Research
The investigator focuses on advancing immunotherapeutic treatments in urologic cancers, particularly exploring combination approaches with established treatments.
- Innovative immunotherapy combinations
- Targeted biological therapies
- Treatment resistance mechanisms
Their work involves evaluating novel immunotherapeutic agents for bladder cancer treatment.
Clinical Innovation
The investigator's work centers on developing therapeutic solutions for patients who have exhausted standard treatment options.
- Treatment optimization strategies
- Drug safety assessment
- Clinical efficacy evaluation
Their research addresses critical gaps in bladder cancer treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.